BMC Gastroenterology (Record no. 1064)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04020nas a22002775i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1471-230X |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610082443.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s||||||||xxkuu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1471-230X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 12876 |
| Source of number or code | local |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | BMC Gastroenterol |
| 245 10 - TITLE STATEMENT | |
| Title | BMC Gastroenterology |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Eduardo Goldani. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | London : |
| Name of producer, publisher, distributor, manufacturer | BioMed Central : |
| -- | Imprint: BioMed Central. |
| 300 ## - online resource | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | BMC Gastroenterology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The journal welcomes manuscripts in the following broad areas of Gastroenterology research: Colorectal Cancer – research in this section includes screening methods (e.g., colonoscopy, fecal tests), genetic and molecular profiling of colorectal tumors, surgical techniques and minimally invasive procedures, chemotherapy, radiotherapy, and immunotherapy approaches, tumor markers and prognostic factors, patient outcomes and survivorship care, and early-onset and hereditary syndromes (e.g., Lynch syndrome, FAP). Epidemiology of gastrointestinal disorders – focuses on population-level understanding, such as prevalence and incidence trends of GI conditions, risk factor studies (e.g., diet, microbiome, lifestyle), geographic and socio-economic disparities in GI health, disease burden and health service utilization, screening program effectiveness, and public health interventions. Gastroesophageal disorders – covers upper GI tract conditions including gastroesophageal reflux disease (GERD), barrett’s esophagus and esophageal cancer, esophagitis and motility disorders (e.g., achalasia), hiatal hernia and swallowing dysfunctions, endoscopic diagnostics and therapies, and acid-suppressive medications and long-term impact. Hepatobiliary and pancreatic disorders – explores liver, bile ducts, gallbladder, and pancreas research such as hepatitis (viral, autoimmune, drug-induced), liver cirrhosis and hepatic fibrosis, hepatocellular carcinoma and cholangiocarcinoma, gallstone disease and biliary obstruction, pancreatitis and pancreatic cancer, transplantation and liver function assessment, and biomarkers and molecular targets. Intestinal Disorders – includes small and large intestine diseases including inflammatory bowel diseases (IBD): Crohn’s disease and ulcerative colitis, irritable bowel syndrome (IBS), celiac disease and gluten sensitivity, intestinal infections and microbiome research, motility disorders and malabsorption syndromes, intestinal ischemia or obstruction, and experimental therapeutics and biologics. Nutrition and Metabolism – tackles interactions between diet, digestive health, and systemic processes such as nutritional interventions in GI diseases, enteral and parenteral nutrition, obesity and its impact on GI tract, gut microbiota and metabolic regulation, nutrient deficiencies and absorption disorders, metabolic liver diseases (e.g., NAFLD, NASH), and role of nutraceuticals and functional foods. As a BMC Series journal, BMC Gastroenterology does not make editorial decisions based on the perceived interest or potential impact of a study. Manuscripts are considered for publication if they are scientifically valid. For research articles, this includes having a clearly defined and sound research question, appropriate methodology and analysis, and adherence to community-agreed standards relevant to the field. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastroenterology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Internal medicine. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastroenterology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Internal Medicine. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goldani, Eduardo. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://bmcgastroenterol.biomedcentral.com/">https://bmcgastroenterol.biomedcentral.com/</a> |
| Public note | Open Access |
No items available.